Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - AERIE PHARMACEUTICALS INC | aeri-20210331.htm |
| EX-32.1 - EX-32.1 - AERIE PHARMACEUTICALS INC | aeri3312021ex321.htm |
| EX-31.2 - EX-31.2 - AERIE PHARMACEUTICALS INC | aeri3312021ex312.htm |
| EX-31.1 - EX-31.1 - AERIE PHARMACEUTICALS INC | aeri3312021ex311.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the filing of the Quarterly Report on Form 10-Q of Aerie Pharmaceuticals, Inc., a Delaware corporation (the “Company”), for the period ended March 31, 2021 (the “Report”), the undersigned, Richard J. Rubino, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
(1)The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2)The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: May 6, 2021 | /s/ RICHARD J. RUBINO | |||||||||||||
| Richard J. Rubino | ||||||||||||||
| Chief Financial Officer | ||||||||||||||
| (Principal Financial and Accounting Officer) | ||||||||||||||